133 / 144
133
RIDE. Ophthalmology. 2013;120:2013-2022.
15. Brown DM, Schmidt-Erfurth U, Do DV, Holz FG, et al. Intravitreal a`ibercept for diabe-
tic macular edema: 100 week results from the VISTA and VIVID studies. Ophthalmolo-
gy. 2015:122(10):2044-2052.
16. Figueira J, Khan J, Nunes S, Sivaprasad S, Rosa A, de Abreu JF, Cunha-Vaz JG, Chong
NV. Prospective randomised controlled trial comparing sub-threshold micropulse dio-
de laser photocoagulation and conventional laser photocoagulation and conventio-
nal green laser for clinically signi%cant diabetic macular oedema. Br J Ophthalmol.
2009;93:1341-1344.
17. Gross JG, Glassman AR, Jampol LM, et al. Panretinal photocoagulation vs intravitreous
ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA.
2015;314:2137-2146.
18. Ebneter A, et al. Prognostic signi%cance of foveal capillary drop-out and previous pan-
retinal photocoagulation for diabetic macular oedema treated with ranibizumab. Br J
Ophthalmol. 2016;100:365-370. doi:10.1136/bjophthalmol-2014-306482
19. Manousaridis K, Talks J. Macular ischaemia: a contraindication for anti-VEGF treatment
in retinal vascular disease? Br J Ophthalmol. 2012;96: 179e 184. doi: 10.1136/bjo-
phthalmol-2011-301087
20. Figueira J, Silva R, Henriques J. Algoritmo de Orientação Terapêutica/Seguimento dos
doentes com Edema Macular Diabético, Retinopatia Diabética, Orientações Clínicas.
Outubro-Dezembro 2015; Suplemento da Revista da Sociedade Portuguesa de Oftal-
mologia.